Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revatio for acute vasodilator test in post-valve surgery pulmonary hypertension
NCT01091012Phase 3Unknown
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ASP-001 in pulmonary hypertension (PH), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Effectiveness of the vasodilator test at 1 day. Status: unknown.
02
Drugs
ASP-001
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01091012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091012.